Dr. James Chou and Dr. Sherine Chan of the Medical University of South Carolina (Musc) (IMAGE)

Medical University of South Carolina

Dr. James Chou and Dr. Sherine Chan of the Medical University of South Carolina (Musc)

Caption

Dr. Chan and Dr. Chou are the founders of Neuroene Therapeutics, an MUSC start-up company that was awarded a 1.5M SBIR Phase II grant to develop a novel anti-seizure compound for drug-resistant epilepsy.

Credit

Sarah Pack, Medical University of South Carolina

Usage Restrictions

Use with appropriate title and credit line

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.